[go: up one dir, main page]

ATE177751T1 - Delta 16 ungesättigtes c17 heterocyclische steroide zur verwendung als steroid c17-20 lyase inhibitoren - Google Patents

Delta 16 ungesättigtes c17 heterocyclische steroide zur verwendung als steroid c17-20 lyase inhibitoren

Info

Publication number
ATE177751T1
ATE177751T1 AT94929935T AT94929935T ATE177751T1 AT E177751 T1 ATE177751 T1 AT E177751T1 AT 94929935 T AT94929935 T AT 94929935T AT 94929935 T AT94929935 T AT 94929935T AT E177751 T1 ATE177751 T1 AT E177751T1
Authority
AT
Austria
Prior art keywords
steroid
delta
unsaturated
lyase inhibitors
steroids
Prior art date
Application number
AT94929935T
Other languages
English (en)
Inventor
Norton P Peet
Joseph P Burkhart
Cynthia P Gates
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Application granted granted Critical
Publication of ATE177751T1 publication Critical patent/ATE177751T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/002—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT94929935T 1993-10-27 1994-09-29 Delta 16 ungesättigtes c17 heterocyclische steroide zur verwendung als steroid c17-20 lyase inhibitoren ATE177751T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14367993A 1993-10-27 1993-10-27

Publications (1)

Publication Number Publication Date
ATE177751T1 true ATE177751T1 (de) 1999-04-15

Family

ID=22505119

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94929935T ATE177751T1 (de) 1993-10-27 1994-09-29 Delta 16 ungesättigtes c17 heterocyclische steroide zur verwendung als steroid c17-20 lyase inhibitoren

Country Status (19)

Country Link
US (3) US5677293A (de)
EP (1) EP0724591B1 (de)
JP (1) JPH09511214A (de)
KR (1) KR960705838A (de)
CN (1) CN1046736C (de)
AT (1) ATE177751T1 (de)
AU (2) AU684844B2 (de)
CA (1) CA2173729C (de)
DE (1) DE69417248T2 (de)
DK (1) DK0724591T3 (de)
ES (1) ES2133582T3 (de)
FI (1) FI961792A0 (de)
GR (1) GR3030263T3 (de)
HU (1) HUT73855A (de)
IL (1) IL111364A0 (de)
NO (1) NO961693D0 (de)
NZ (1) NZ274694A (de)
WO (1) WO1995011914A1 (de)
ZA (1) ZA948310B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2330611A1 (en) 1998-05-22 1999-12-02 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
AU6087700A (en) * 1999-07-15 2001-02-05 Procter & Gamble Company, The Nitrogen-containing steroid compounds and their use to regulate hair growth
WO2003009815A2 (en) 2001-07-25 2003-02-06 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
US6562457B1 (en) 2001-10-31 2003-05-13 E. I. Du Pont De Nemours And Company Polyether ester elastomer comprising polytrimethylene ether ester soft segment and tetramethylene ester hard segment
US8569275B2 (en) 2002-08-28 2013-10-29 Harbor Therapeutics, Inc. Steroids having 7-oxgen and 17-heteroaryl substitution
US8847766B2 (en) 2005-04-28 2014-09-30 Proteus Digital Health, Inc. Pharma-informatics system
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
EP2398500B1 (de) 2009-02-20 2019-03-13 2-BBB Medicines B.V. Arzneiabgabesystem auf glutathion-basis
BRPI1011188B1 (pt) 2009-05-06 2019-10-15 Laboratory Skin Care, Inc. Composições de liberação dérmica compreendendo complexos de partículas de agente ativo-fosfato de cálcio e métodos para usar as mesmas
US20110178065A1 (en) * 2010-01-15 2011-07-21 Biomarin Pharmaceutical Inc. Novel cyp17 inhibitors
JP5998137B2 (ja) 2010-08-04 2016-09-28 ペルフィキュア ファーマシューティカルズ，インコーポレイテッド 前立腺癌を処置するための併用療法
CN102746358B (zh) * 2011-04-22 2016-02-10 天津金耀集团有限公司 一种合成孕甾21位溴化物的工艺
CN102898495B (zh) * 2012-11-12 2014-11-26 浙江神洲药业有限公司 醋酸阿比特龙酯的制备方法
CN103059091B (zh) * 2012-11-22 2017-04-19 常州靶点医药科技有限公司 一种避免重金属残留的醋酸阿比特龙的制备方法
CA2902335C (en) 2013-03-14 2021-09-14 Pellficure Pharmaceuticals, Inc. Novel therapy for prostate carcinoma
WO2016040896A1 (en) 2014-09-12 2016-03-17 Pellficure Pharmaceuticals, Inc. Compositions and methods for treatment of prostate carcinoma
HUP1500055A1 (hu) 2015-02-09 2016-08-29 Druggability Technologies Ip Holdco Ltd Abirateron acetát komplexei, eljárás elõállításukra, és az azokat tartalmazó gyógyászati készítmények
CA3044812A1 (en) 2016-10-24 2018-05-03 Pellficure Pharmaceuticals Inc. Pharmaceutical compositions of 5-hydroxy-2-methylnaphthalene-1,4-dione
CN106866773A (zh) * 2017-02-14 2017-06-20 西北农林科技大学 一组具有抗癌活性吡唑基甾体衍生物的制备方法及应用
CN116621905B (zh) * 2023-06-06 2025-07-15 西北农林科技大学 双烯噻唑类衍生物及其合成方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1081647A (en) * 1965-04-01 1967-08-31 Shionogi & Co Furan compounds
AT253975B (de) * 1965-06-15 1967-05-10 Carinthia Elektrogeraete Ges M Trockenrasierapparat
US3436390A (en) * 1966-05-24 1969-04-01 American Home Prod 4,4-dihydroxy-2-butenoic acid lactones
US3398138A (en) * 1966-05-24 1968-08-20 American Home Prod Novel cardenolides and derivatives
US4259240A (en) * 1979-09-28 1981-03-31 Advance Biofactures Corporation Synthesis of furyl intermediates, and cardenolides and their isomers prepared therefrom
US4380624A (en) * 1981-07-31 1983-04-19 Advance Biofactures Corp. Novel isomers of bufalin and resibufogenin and their preparation
US4523917A (en) * 1983-12-27 1985-06-18 Dana Corporation Variable pitch diameter torque sensing pulley assembly
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
GB2265624B (en) * 1992-03-31 1995-04-19 British Tech Group 17-substituted steroids useful in cancer treatment
DE4221636C1 (de) * 1992-07-01 1994-03-31 Sigma Tau Ind Farmaceuti Cyclopentanperhydrophenanthren-17beta-(3-furyl)-3-Derivate

Also Published As

Publication number Publication date
EP0724591B1 (de) 1999-03-17
JPH09511214A (ja) 1997-11-11
CN1046736C (zh) 1999-11-24
AU695341B2 (en) 1998-08-13
ZA948310B (en) 1995-06-14
NZ274694A (en) 1998-01-26
CA2173729C (en) 2001-05-15
FI961792A7 (fi) 1996-04-26
KR960705838A (ko) 1996-11-08
CN1133596A (zh) 1996-10-16
HU9601113D0 (en) 1996-07-29
NO961693L (no) 1996-04-26
IL111364A0 (en) 1994-12-29
DK0724591T3 (da) 1999-09-27
DE69417248T2 (de) 1999-08-19
EP0724591A1 (de) 1996-08-07
US5677293A (en) 1997-10-14
DE69417248D1 (de) 1999-04-22
AU3993097A (en) 1998-01-08
FI961792L (fi) 1996-04-26
HUT73855A (en) 1996-09-30
NO961693D0 (no) 1996-04-26
AU684844B2 (en) 1998-01-08
AU7922394A (en) 1995-05-22
GR3030263T3 (en) 1999-08-31
FI961792A0 (fi) 1996-04-26
CA2173729A1 (en) 1995-05-04
ES2133582T3 (es) 1999-09-16
US5965548A (en) 1999-10-12
US5977094A (en) 1999-11-02
WO1995011914A1 (en) 1995-05-04

Similar Documents

Publication Publication Date Title
ATE177751T1 (de) Delta 16 ungesättigtes c17 heterocyclische steroide zur verwendung als steroid c17-20 lyase inhibitoren
DE69423631D1 (de) Thermit-zusammensetzungen zur verwendung als gaserzeugende körper
DE69821376D1 (de) Verfahren zur proteinrückfaltung durch verwendung zwitterionischer wirkstoffe von niedrigem molekulargewicht
ATE250077T1 (de) Steroid sulfataseinhibitoren, verfahren zu ihrer herstellung und verwendung
DE69838146D1 (de) Androgene steroidderivate und ein verfahren zur herstellung und verwendung derselben
ATE67211T1 (de) C17-20-lyase-inhibitoren.
DE59806541D1 (de) Verwendung von alkoholen als additive für putze und/oder mörtel
FI955642A0 (fi) 4-amino-17beta-(syklopropyylioksi)androst-4-en-3-oni, 4-amino-17beta-(syklopropyliamino)androst-4-en-3-oni ja näitä muistuttavat yhdisteet C17-20-lyaasin ja 5alfa-reduktaasin inhibiittoreina
NO20023276D0 (no) Fremgangsmåte til å fremstille betulinsyre
DE69502223D1 (de) Neue Verwendung von 1Alpha-fluor-25-hydroxy-16-en-23-yn-cholecalciferol
DE69119992D1 (de) 4-Amino-delta4-Steroide und ihre Verwendung als Inhibitoren von 5alpha-Reduktase
NO943765L (no) Aryloksybenzen-herbicidmidler
ATE277060T1 (de) 1,5-anhydro-d-fruktose substituiert mit einer hydrophoben gruppe zur verwendung als antioxidant und/oder emulgator
CA2332652A1 (en) .delta.16 unsaturated c17 heterocyclic steroids useful as steroid c17-20 lyase inhibitors
ATE277071T1 (de) Durch 11-beta-aryl-17,17-spirothiolan substituierte steroide
NO944124L (no) 17 yre
ATE124417T1 (de) 2,19-methylenoxy- und 2,19-methylenthiogebrückte steroide und ihre verwendung als inhibitoren von aromatase und 19-hydroxylase.
GB9808018D0 (en) Soil test
DE59811742D1 (de) Verfahren zur Prozessführung eines Anodenbrennofens
DE69628192D1 (de) Darstellung von esterderivaten von steroiden
MX9709199A (es) Metodos y composiciones para atraer y controlar termitas.
NO891776D0 (no) Steroide 5-alfa-reduktase-inhibitorer.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee